[A case of small cell lung carcinoma associated with pneumoconiosis who responded well to the over twenty chemotherapy treatments, resulting in prolonged survival].

Abstract

In a 62-year-old man with pneumoconiosis (management 4), small cell lung carcinoma (intermediate cell type) was detected at the routine health examination for pneumoconiosis. The stage of the disease was III B (T2N3M0). Chemotherapy was undertaken over twenty times, resulting in a prolonged survival time (42.5 months). A case of this kind with small cell lung cancer responding well to repeated chemotherapy (decreased tumor size and tumor marker) until the terminal stage seems relatively rare and valuable.

• Authors: K Sassa, Y Mizushima, Y Yoshida, K Shinoda, M Kobayashi
• Journal: Gan to kagaku ryoho. Cancer & chemotherapy (Gan To Kagaku Ryoho) Vol. 24 Issue 5 Pg. 609-12 (Mar 1997) ISSN: 0385-0684 [Print] Japan
• PMID: 9087297 (Publication Type: Case Reports, English Abstract, Journal Article)

Chemical References

• Vincristine
• Etoposide
• Doxorubicin
• Cyclophosphamide
• Cisplatin

Topics

• Antineoplastic Combined Chemotherapy Protocols (therapeutic use)
• Carcinoma, Small Cell (complications, drug therapy)
• Cisplatin (administration & dosage)
• Cyclophosphamide (administration & dosage)
• Doxorubicin (administration & dosage)
• Drug Administration Schedule
• Etoposide (administration & dosage)
• Humans
• Lung Neoplasms (complications, drug therapy)
• Male
• Middle Aged
• Pneumoconiosis (complications)
• Survivors
• Vincristine (administration & dosage)